ARTICLE | Company News
The Genentech unit of Roche granted Mylan a license to market its proposed biosimilar of Herceptin trastuzumab, MYL-1401O, ending litigation between the companies. Mylan agreed to withdraw inter parte...
BCIQ Target Profiles
Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)